Kalkan, Rasime,  a  b  Prof. Dr.  c  d <br/><br/>
IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme  
Rasime Kalkan, Emine Ikbal Atlı, Muhsin Özdemir, Evrim Çiftçi, Hasan Emre Aydın, Sevilhan Artan, Ali Arslantaş. 
 -  Elsevier Science,  2015. 
<br/><br/> Purpose: To establish the frequency of IDH1 mutations and MGMT methylation in primary glioblastomas. Experimental design: We screened primary glioblastoma multiforme (GBM) in a population-based study for IDH1 mutations and MGMT methylation and correlated them with clinical data.  
<br/><br/><label>ISSN: </label>0378-1119  
<br/><br/><label>Nat. Bib. Agency Control No.: </label>WOS:000345483100011 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Yakın Doğu Üniversitesi Makale<br/>Near East University Article<br/>Diffuse Gliomas
<br/><br/><label>LC Class. No.: </label>QP624